Published in Sci Rep on April 05, 2017
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med (2006) 15.04
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet (2012) 1.88
Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101. Mol Cancer Ther (2003) 1.87
Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging (2006) 1.57
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production. J Neurosci (2009) 1.47
Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology (2005) 1.47
Phosphatidylinositol 3-kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones. J Neurochem (2002) 1.39
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging (2004) 1.36
The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. PLoS Pathog (2008) 1.34
Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions. J Neurosci (2008) 1.34
Boronic acids in molecular self-assembly. Chem Asian J (2008) 1.27
Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients. Int J Cancer (2009) 1.24
Neuroinflammation: modulation by flavonoids and mechanisms of action. Mol Aspects Med (2011) 1.24
Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem (2007) 1.24
Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi. Acta Trop (2007) 1.23
Predicting the virulence of MRSA from its genome sequence. Genome Res (2014) 1.23
Noxious stimulation induces Trk receptor and downstream ERK phosphorylation in spinal dorsal horn. Mol Cell Neurosci (2002) 1.22
Exploiting the reversible covalent bonding of boronic acids: recognition, sensing, and assembly. Acc Chem Res (2012) 1.21
Waiting time for breast cancer treatment in Alberta. Can J Public Health (2004) 1.20
Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem (2003) 1.14
Hydrogen peroxide-mediated phosphorylation of ERK1/2, Akt/PKB and JNK in cortical neurones: dependence on Ca(2+) and PI3-kinase. J Neurochem (2002) 1.14
(-)Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons. J Neurochem (2007) 1.13
The role of ethnicity and culture in body image and disordered eating among males. Clin Psychol Rev (2007) 1.13
Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol Psychiatry (2002) 1.12
CB2 cannabinoid receptors promote mouse neural stem cell proliferation. Eur J Neurosci (2007) 1.08
Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy. Clin Microbiol Rev (2004) 1.06
MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging (2002) 1.05
Boronic acid building blocks: tools for sensing and separation. Chem Commun (Camb) (2010) 1.05
Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J (2003) 1.04
Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy. Cancer Res (2013) 1.04
Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease. J Neurochem (2006) 1.04
The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys (2009) 1.03
Activity-dependent phosphorylation of Akt/PKB in adult DRG neurons. Eur J Neurosci (2005) 1.03
Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Aβ production. Hum Mol Genet (2012) 1.02
An enantioselective fluorescent sensor for sugar acids. J Am Chem Soc (2004) 1.02
In vitro antimalarial susceptibility profile and prcrt/pfmdr-1 genotypes of Plasmodium falciparum field isolates from Malawi. Am J Trop Med Hyg (2007) 1.01
Analysis of skin wound images using digital color image processing: a preliminary communication. Int J Low Extrem Wounds (2004) 0.99
Malaria chemotherapy. Adv Parasitol (2006) 0.99
A computational characterization of boron-oxygen multiple bonding in HN=CH-CH=CH-NH-BO. J Phys Chem A (2008) 0.99
Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b. PLoS One (2012) 0.98
Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochem Res (2011) 0.97
The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings. J Neurochem (2003) 0.97
Boronic acid building blocks: tools for self assembly. Chem Commun (Camb) (2010) 0.95
Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res (2003) 0.94
Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress. J Neurochem (2004) 0.94
Bandaging technique after knee replacement. Acta Orthop (2005) 0.93
In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug. J Am Chem Soc (2014) 0.92
Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology. J Neural Transm (Vienna) (2008) 0.91
Selective sensing of saccharides using simple boronic acids and their aggregates. Chem Soc Rev (2013) 0.91
Glucose sensing via aggregation and the use of "knock-out" binding to improve selectivity. J Am Chem Soc (2013) 0.91
Cholinergic imbalance in the multiple sclerosis hippocampus. Acta Neuropathol (2011) 0.91
CAD/CAM/AM applications in the manufacture of dental appliances. Am J Orthod Dentofacial Orthop (2012) 0.90
Neuroprotective effects of phenolic antioxidant tBHQ associate with inhibition of FoxO3a nuclear translocation and activity. J Neurochem (2012) 0.90
Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells. J Neurochem (2008) 0.89
Dye displacement assay for saccharide detection with boronate hydrogels. Chem Commun (Camb) (2008) 0.89
Simple protocol for NMR analysis of the enantiomeric purity of diols. Org Lett (2006) 0.89
"Click-fluors": modular fluorescent saccharide sensors based on a 1,2,3-triazole ring. J Org Chem (2008) 0.88
The development of boronic acids as sensors and separation tools. Chem Rec (2012) 0.88
Cell based cancer vaccines: regulatory and commercial development. Vaccine (2007) 0.88
Pro-oxidant diet enhances β/γ secretase-mediated APP processing in APP/PS1 transgenic mice. Neurobiol Aging (2010) 0.87
The association between childhood maltreatment and gambling problems in a community sample of adult men and women. Psychol Addict Behav (2010) 0.87
Abeta(1-42) modulation of Akt phosphorylation via alpha7 nAChR and NMDA receptors. Neurobiol Aging (2007) 0.87
Probing disease-related proteins with fluorogenic composite materials. Chem Soc Rev (2014) 0.86
A near-infrared colorimetric fluorescent chemodosimeter for the detection of glutathione in living cells. Chem Commun (Camb) (2014) 0.86
Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones. J Neurochem (2004) 0.86
Chiral mono boronic acid as fluorescent enantioselective sensor for mono alpha-hydroxyl carboxylic acids. J Org Chem (2008) 0.86
CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients. Neurobiol Aging (2012) 0.86
Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease. Neurobiol Aging (2005) 0.86
Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels. J Pharm Pharmacol (2008) 0.86
Simple protocol for NMR analysis of the enantiomeric purity of primary amines. Org Lett (2006) 0.85
Direct sensing of fluoride in aqueous solutions using a boronic acid based sensor. Chem Commun (Camb) (2014) 0.85
Analysis of protein glycation using phenylboronate acrylamide gel electrophoresis. Proteomics (2010) 0.85
Frequency and significance of IgG4 immunohistochemical staining in liver explants from patients with primary sclerosing cholangitis. Int J Exp Pathol (2014) 0.85
Boronic acid based modular fluorescent sensors for glucose. J Fluoresc (2004) 0.85
Electrochemical method for the determination of enantiomeric excess of binol using redox-active boronic acids as chiral sensors. J Am Chem Soc (2010) 0.84
Tumour necrosis factor alpha induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration. J Neurochem (2010) 0.84
Chiral binol-bisboronic acid as fluorescence sensor for sugar acids. Angew Chem Int Ed Engl (2004) 0.84
Capturing intercellular sugar-mediated ligand-receptor recognitions via a simple yet highly biospecific interfacial system. Sci Rep (2013) 0.84
Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia. Dement Geriatr Cogn Disord (2008) 0.84
Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease. Neurobiol Dis (2006) 0.84
Pulsed radiofrequency for chronic testicular pain-a preliminary report. Pain Med (2009) 0.84
Altered NCAM expression associated with the cholinergic system in Alzheimer's disease. J Alzheimers Dis (2010) 0.84
Low Raman-noise correlated photon-pair generation in a dispersion-engineered chalcogenide As2S3 planar waveguide. Opt Lett (2012) 0.84
Fluorescent nanosensors via photoinduced polymerization of hydrophobic inorganic quantum dots for the sensitive and selective detection of nitroaromatics. Anal Chem (2015) 0.83
Glucose selective surface plasmon resonance-based bis-boronic acid sensor. Analyst (2013) 0.83
Detection of anions using a fluorescent alizarin-phenylboronic acid ensemble. Chem Commun (Camb) (2005) 0.83
Examining the predictive validity of low-risk gambling limits with longitudinal data. Addiction (2011) 0.83
Single-frequency fiber laser operating at 2.9 μm. Opt Lett (2013) 0.83
Boron based anion receptors as sensors. Chem Soc Rev (2010) 0.83
Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue. Brain Pathol (2013) 0.83
Reversible electrochemical modulation of fluorescence and selective sensing of ascorbic acid using a DCIP-CA-CdTe QD system. Analyst (2012) 0.83
Polarization-dependent effects in point-by-point fiber Bragg gratings enable simple, linearly polarized fiber lasers. Opt Express (2009) 0.83
Selective fluorescence detection of monosaccharides using a material composite formed between graphene oxide and boronate-based receptors. ACS Appl Mater Interfaces (2014) 0.83